首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Persistent sterile peritoneal inflammation after catheter removal for refractory bacterial peritonitis predicts full-blown encapsulating peritoneal sclerosis
【24h】

Persistent sterile peritoneal inflammation after catheter removal for refractory bacterial peritonitis predicts full-blown encapsulating peritoneal sclerosis

机译:顽固性细菌性腹膜炎拔除导管后持续的无菌性腹膜炎预示着成熟的包膜性腹膜硬化

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Encapsulating peritoneal sclerosis (EPS) is the most serious complication of peritoneal dialysis, having high morbidity and mortality. To improve outcomes, early diagnosis is needed to direct treatment during the early inflammatory phase. However, in the early inflammatory phase, clinical features are nonspecific, and no reliable diagnostic criteria have been established. Because bacterial peritonitis and termination of dialysis are two important risk factors triggering the progression of EPS, patients with refractory bacterial peritonitis necessitating dialysis catheter removal are at particularly high risk of developing EPS. Many of these patients might indeed experience non-resolving sterile peritonitis (probably the inflammatory phase of EPS) before progression to full-blown disease (that is, the presence of intestinal obstruction). We undertook a retrospective study to compare, in this particular situation, the clinical characteristics of patients with or without sterile peritoneal inflammation, assessing their clinical outcomes in terms of short-term mortality and the chance of developing full-blown EPS. Methods: Our retrospective review included 62 patients whose dialysis catheter was removed because of refractory peritonitis between January 2005 and December 2010. Results: Of the 62 patients identified, 39 (63%) had persistent sterile peritoneal inflammation ("high-risk" group, n = 39), and 23 (37%) had resolution of inflammation without significant intra-abdominal collection after catheter withdrawal ("control" group, n = 23). Compared with the control group, the high-risk group had a significantly longer PD duration (71.6 ± 43.3 months vs 42.3 ± 29.9 months, p = 0.003), a higher dialysate-to-plasma ratio (D/P) of creatinine (0.768 ± 0.141 vs 0.616 ± 0.091, p = 0.004), and a higher computed tomography score for EPS (7.69 ± 2.98 vs 1.00 ± 1.00, p < 0.001). During the 6-month study period, the high-risk group had a higher chance of developing full-blown EPS (31% vs 0%, p = 0.002) and a higher 6-month all-cause mortality (36% vs 4.3%, p = 0.004). Conclusions: Persistent sterile peritoneal inflammation was common after dialysis catheter removal for refractory bacterial peritonitis, and the patients with such inflammation were at high risk of progression to full-blown EPS.
机译:背景:封装性腹膜硬化症(EPS)是腹膜透析最严重的并发症,具有较高的发病率和死亡率。为了改善结局,需要早期诊断以在早期炎症阶段指导治疗。然而,在炎性早期,临床特征是非特异性的,并且尚未建立可靠的诊断标准。由于细菌性腹膜炎和透析终止是触发EPS进展的两个重要危险因素,因此难治性细菌性腹膜炎患者需要透析导管的拔除特别容易发生EPS。这些患者中有许多确实可能在发展为成熟疾病(即存在肠梗阻)之前经历了无法解决的无菌性腹膜炎(可能是EPS的炎症期)。我们进行了一项回顾性研究,以比较这种特殊情况下有或没有无菌性腹膜炎症的患者的临床特征,并根据短期死亡率和发展成熟的EPS的机会评估其临床结局。方法:我们的回顾性研究纳入了2005年1月至2010年12月之间因难治性腹膜炎而拔掉了透析导管的62例患者。结果:在确定的62例患者中,有39例(63%)持续存在无菌性腹膜炎(“高危”组, n = 39),有23位(37%)的炎症消退,在撤回导管后没有明显的腹部内收集物(“对照组”,n = 23)。与对照组相比,高危组的PD持续时间明显更长(71.6±43.3个月vs 42.3±29.9个月,p = 0.003),并且肌酐的透析液与血浆比率(D / P)更高(0.768) ±0.141 vs 0.616±0.091,p = 0.004),EPS的计算机断层扫描得分更高(7.69±2.98 vs 1.00±1.00,p <0.001)。在为期6个月的研究期内,高风险组发生完全成熟EPS的机会更高(31%vs 0%,p = 0.002),并且6个月全因死亡率更高(36%vs 4.3% ,p = 0.004)。结论:对于难治性细菌性腹膜炎,拔除透析导管后,持续性无菌性腹膜炎很常见,患有这种炎症的患者极有可能发展为成熟的EPS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号